Dumont FJ et al. |
A tacrolimus-related immunosuppressant with reduced toxicity. |
1998 |
Transplantation |
pmid:9448138
|
Miyauchi T et al. |
Effect of donor-specific splenocytes via portal vein and FK506 in rat small bowel transplantation. |
1998 |
Transplantation |
pmid:9448139
|
Hernández D et al. |
Randomized controlled study comparing reduced calcineurin inhibitors exposure versus standard cyclosporine-based immunosuppression. |
2007 |
Transplantation |
pmid:17893603
|
Koprak S et al. |
Depletion of the mature CD4+8- thymocyte subset by FK506 analogs correlates with their immunosuppressive and calcineurin inhibitory activities. |
1996 |
Transplantation |
pmid:8623162
|
Khanafer A et al. |
Increased nitric oxide production during acute rejection in kidney transplantation: a useful marker to aid in the diagnosis of rejection. |
2007 |
Transplantation |
pmid:17876269
|
Zoppo A et al. |
Trimetazidine counteracts tacrolimus nephrotoxicity in a hypertensive liver transplant patient. |
1999 |
Transplantation |
pmid:10551656
|
Takahara S et al. |
The in vitro immunosuppressive effect of deoxymethylspergualin in man as compared with FK506 and cyclosporine. |
1992 |
Transplantation |
pmid:1373537
|
Johnson MC et al. |
QT prolongation and Torsades de Pointes after administration of FK506. |
1992 |
Transplantation |
pmid:1373538
|
Metcalfe SM and Richards FM |
Cyclosporine, FK506, and rapamycin. Some effects on early activation events in serum-free, mitogen-stimulated mouse spleen cells. |
1990 |
Transplantation |
pmid:1691537
|
Gathogo E et al. |
Impact of Tacrolimus Compared With Cyclosporin on the Incidence of Acute Allograft Rejection in Human Immunodeficiency Virus-Positive Kidney Transplant Recipients. |
2016 |
Transplantation |
pmid:26413990
|
Demmers MW et al. |
Limited efficacy of immunosuppressive drugs on CD8+ T cell-mediated and natural killer cell-mediated lysis of human renal tubular epithelial cells. |
2014 |
Transplantation |
pmid:24704664
|
Xue F et al. |
Immune cell functional assay in monitoring of adult liver transplantation recipients with infection. |
2010 |
Transplantation |
pmid:20010326
|
Papadopoulos-Köhn A et al. |
Daily low-dose tacrolimus is a safe and effective immunosuppressive regimen during telaprevir-based triple therapy for hepatitis C virus recurrence after liver transplant. |
2015 |
Transplantation |
pmid:25208324
|
Manitpisitkul W et al. |
Maintenance immunosuppressive agents as risk factors for BK virus nephropathy: a case-control study. |
2009 |
Transplantation |
pmid:19584685
|
Fujimura Y and Owen RL |
Tacrolimus (FK506) and cyclosporine reduce the uptake and transport of particles into rabbit Peyer's patches. |
2002 |
Transplantation |
pmid:11965030
|
Kaufman DB et al. |
Mycophenolate mofetil and tacrolimus as primary maintenance immunosuppression in simultaneous pancreas-kidney transplantation: initial experience in 50 consecutive cases. |
1999 |
Transplantation |
pmid:10071032
|
Khanna A et al. |
Tacrolimus induces increased expression of transforming growth factor-beta1 in mammalian lymphoid as well as nonlymphoid cells. |
1999 |
Transplantation |
pmid:10071036
|
Benigni A et al. |
The acute effect of FK506 and cyclosporine on endothelial cell function and renal vascular resistance. |
1992 |
Transplantation |
pmid:1279848
|
Mor E et al. |
Late-onset acute rejection in orthotopic liver transplantation--associated risk factors and outcome. |
1992 |
Transplantation |
pmid:1279849
|
Barraclough KA et al. |
NR1I2 polymorphisms are related to tacrolimus dose-adjusted exposure and BK viremia in adult kidney transplantation. |
2012 |
Transplantation |
pmid:23095803
|
Diem HV et al. |
Pediatric liver transplantation for biliary atresia: results of primary grafts in 328 recipients. |
2003 |
Transplantation |
pmid:12777858
|
Smets F et al. |
Ratio between Epstein-Barr viral load and anti-Epstein-Barr virus specific T-cell response as a predictive marker of posttransplant lymphoproliferative disease. |
2002 |
Transplantation |
pmid:12042647
|
Heidt S et al. |
Effects of immunosuppressive drugs on purified human B cells: evidence supporting the use of MMF and rapamycin. |
2008 |
Transplantation |
pmid:19005412
|
Serón D et al. |
Immunophenotype of infiltrating cells in protocol renal allograft biopsies from tacrolimus-versus cyclosporine-treated patients. |
2007 |
Transplantation |
pmid:17353788
|
Andoh TF et al. |
Enhancement of FK506 nephrotoxicity by sodium depletion in an experimental rat model. |
1994 |
Transplantation |
pmid:7509514
|
Imado T et al. |
Effect of FK506 on donor T-cell functions that are responsible for graft-versus-host disease and graft-versus-leukemia effect. |
2004 |
Transplantation |
pmid:14966413
|
Higgins RM et al. |
Acute rejection after renal transplantation is reduced by approximately 50% by prior therapeutic blood transfusions, even in tacrolimus-treated patients. |
2004 |
Transplantation |
pmid:14966430
|
Wallia A et al. |
Posttransplant hyperglycemia is associated with increased risk of liver allograft rejection. |
2010 |
Transplantation |
pmid:20098286
|
Araki M et al. |
Posttransplant diabetes mellitus in kidney transplant recipients receiving calcineurin or mTOR inhibitor drugs. |
2006 |
Transplantation |
pmid:16477217
|
Vivarelli M et al. |
Effect of different immunosuppressive schedules on recurrence-free survival after liver transplantation for hepatocellular carcinoma. |
2010 |
Transplantation |
pmid:20098287
|
Woodle ES et al. |
A multicenter trial of FK506 (tacrolimus) therapy in refractory acute renal allograft rejection. A report of the Tacrolimus Kidney Transplantation Rescue Study Group. |
1996 |
Transplantation |
pmid:8830821
|
Jain AB et al. |
A prospective randomized trial of tacrolimus and prednisone versus tacrolimus, prednisone, and mycophenolate mofetil in primary adult liver transplant recipients: an interim report. |
1998 |
Transplantation |
pmid:9846530
|
Wannhoff A et al. |
Increased levels of rivaroxaban in patients after liver transplantation treated with cyclosporine A. |
2014 |
Transplantation |
pmid:25022236
|
Pacifico L et al. |
Tacrolimus and food allergy. |
2003 |
Transplantation |
pmid:14688538
|
Gullestad L et al. |
Everolimus with reduced calcineurin inhibitor in thoracic transplant recipients with renal dysfunction: a multicenter, randomized trial. |
2010 |
Transplantation |
pmid:20061999
|
Ochiai T et al. |
Optimal serum trough levels of FK506 in renal allotransplantation of the beagle dog. |
1989 |
Transplantation |
pmid:2474208
|
Ciancio G et al. |
Review of major clinical trials with mycophenolate mofetil in renal transplantation. |
2005 |
Transplantation |
pmid:16251852
|
Vyas S et al. |
Outcome of twin pregnancy in a renal transplant recipient treated with tacrolimus. |
1999 |
Transplantation |
pmid:10030303
|
Muthukkumar S et al. |
Rapamycin, a potent immunosuppressive drug, causes programmed cell death in B lymphoma cells. |
1995 |
Transplantation |
pmid:7544036
|
Muraki T et al. |
Antithrombotic effect of FK506 versus prothrombotic effect of cyclosporine in vivo. |
1995 |
Transplantation |
pmid:7544038
|
Fridell JA et al. |
Causes of mortality beyond 1 year after primary pediatric liver transplant under tacrolimus. |
2002 |
Transplantation |
pmid:12499888
|
Metcalfe S and Milner J |
Evidence that FK506 and rapamycin block T cell activation at different sites relative to early reversible phosphorylation involving the protein phosphatases PP1 and PP2A. |
1991 |
Transplantation |
pmid:1710844
|
Jain AB et al. |
Capillary blood versus arterial or venous blood for tacrolimus monitoring in liver transplantation. |
1995 |
Transplantation |
pmid:7545836
|
Gillard P et al. |
Early alteration of kidney function in nonuremic type 1 diabetic islet transplant recipients under tacrolimus-mycophenolate therapy. |
2014 |
Transplantation |
pmid:24770614
|
Vincenti F et al. |
One-year follow-up of an open-label trial of FK506 for primary kidney transplantation. A report of the U.S. Multicenter FK506 Kidney Transplant Group. |
1996 |
Transplantation |
pmid:8669100
|
Brito-Costa A et al. |
Factors Associated With Changes in Body Composition Shortly After Orthotopic Liver Transplantation: The Potential Influence of Immunosuppressive Agents. |
2016 |
Transplantation |
pmid:27136260
|
de Jonge H et al. |
Reduced C0 concentrations and increased dose requirements in renal allograft recipients converted to the novel once-daily tacrolimus formulation. |
2010 |
Transplantation |
pmid:20592652
|
Bazerbachi F et al. |
Pancreas-after-kidney versus synchronous pancreas-kidney transplantation: comparison of intermediate-term results. |
2013 |
Transplantation |
pmid:23183776
|
Tricot L et al. |
Tacrolimus-induced alopecia in female kidney-pancreas transplant recipients. |
2005 |
Transplantation |
pmid:16371923
|
Bolley R et al. |
Tacrolimus-induced nephrotoxicity unmasked by induction of the CYP3A4 system with St John's wort. |
2002 |
Transplantation |
pmid:11923712
|